Attached files
file | filename |
---|---|
EX-99.1 - PRESS RELEASE - Event Cardio Group Inc. | sunrise_ex991.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
Current Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
October 30, 2014
Date of Report (Date of earliest event reported)
SUNRISE HOLDINGS, LIMITED |
(Exact name of registrant as specified in its charter) |
Nevada |
0-52518 |
20-8051714 |
||
(State or other jurisdiction of Incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
2798 Thamesgate Dr. Mississauga, Ontario, Canada |
L4T 4E8 |
|
(Address of principal executive offices) |
(Zip Code) |
Registrant’s telephone number, including area code: 289-407-4377
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
¨ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
¨ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
¨ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
ITEM 7.01 REGULATION FD DISCLOSURE
On October 30, 2014, Sunrise Holdings Limited (“the “Company”) issued a press release announcing that its wholly owned subsidiary had entered into a Licensing Agreement with Life Medical Technologies, Inc. with respect to Life Medical’s Breastcare DTS™. A copy of the Company’s press release is attached hereto as Exhibit 99.1.
The information contained in this Current Report shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS
(b) Exhibits |
Description |
|
|
|
|
99.1 |
Text of press release issued by Sunrise Holdings, Limited on October 30, 2014 announcing the entry into a Licensing Agreement with Life Medical Technologies, Inc. |
2
|
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Sunrise Holdings Limited |
|||
Dated: October 30, 2014 |
By: |
/s/ John Bentivoglio |
|
Name: |
John Bentivoglio |
||
Title: |
Chief Executive Officer |
3
|